Estrogen Receptor Degrader (SERD) Drugs: A New Era in Hormone-Driven Cancer Therapy
Introduction Hormone-dependent cancers, particularly estrogen receptor–positive (ER+) breast cancer, represent a significant portion of cancer diagnoses worldwide. Over the past few decades,...